Drug intelligence / Profile preview

proline-arginine-hydroxymethyl rhodamine green

Development stage
Preclinical
Lead developer
The University of Tokyo
Modality
Peptides, Small Molecules
Administration
Topical
01

Overview

PR-HMRG is a novel, spray-type fluorescent probe developed for the intraoperative rapid detection of malignant glioma, specifically glioblastoma. It consists of a hydroxymethyl rhodamine green (HMRG) fluorescent scaffold conjugated to a proline-arginine dipeptide. The probe is designed to be enzymatically activated by Calpain-1, a protease that is significantly overexpressed in glioma tumor tissues. Upon cleavage of the dipeptide by Calpain-1, the HMRG scaffold becomes highly fluorescent, allowing for real-time visualization of tumor margins during surgery. This probe aims to address limitations of current surgical adjuncts like 5-aminolevulinic acid (5-ALA), such as false results and the inability to re-administer the agent during a single procedure.

Other names
proline-arginine-HMRG
02

Targets

CAPN (Schistosoma calpain large subunit family)

Beyond the preview

Go deeper on proline-arginine-hydroxymethyl rhodamine green.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on proline-arginine-hydroxymethyl rhodamine green.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call